
Moderna’s COVID-19 Vaccine Spikevax Receives Full FDA Approval for Children Aged 6 Months to 11 Years at “Increased Risk”
by Jim Hᴏft, TGP The U.S. Food and Drug Administration (FDA) has officially granted full approval to Moderna’s controversial mRNA COVID-19 vaccine, Spikevax, for children as young as 6 months old…[...]
Read More